Millar, Telemetry Research partner to offer TRM53P implantable transmitters

NewsGuard 100/100 Score

Millar Instruments, Inc., a medical device manufacturing firm and developer of pressure sensing technology, has released the TRM53P implantable transmitter through the partnership with Telemetry Research, Ltd. The TRM53P is the world's first, fully implantable transmitter that combines Millar's gold standard solid-state pressure sensors with Telemetry Research's next generation telemetry technology.

The TRM53P provides high-fidelity pressure measurements that deliver accurate pressures including dP/dT and LVP. The solid-state sensor, mounted at the tip of the catheter, enables pressure to be measured in almost any location. Additionally, the sensor removes the need for gel and minimizes clotting.

This system is truly next generation due to the digital data transmission and wireless inductive power charging capabilities. The digital data transmission allows for a larger monitoring range and true cohabitation of multiple animals. Wireless inductive power charging enables 24/7 monitoring for the lifetime of the animal.

The device offers unprecedented long-term reliability, thus reducing overall cost. The integrated rechargeable battery means refurbishment is not required, allowing straightforward transmitter reuse with a simple cleaning of the device.

Applications may include cardiovascular, sleep research, toxicology, safety testing, neuroscience and behavioral studies. With the combination of next generation technology and solid state pressure sensors, the TRM53P is designed to redefine the standard in pressure monitoring.

SOURCE Millar Instruments, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research sheds light on how GLP-1 obesity drugs may change food cravings